Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation
Abstract Background Novel circulating biomarkers may help in understanding the underlying mechanisms of atrial fibrillation (AF), a challenge for AF management and prevention of cardiovascular (CV) events. Whether glycosylation affects the prognostic value of N-terminal pro-B type natriuretic peptid...
Guardado en:
Autores principales: | Lidia Staszewsky, Jennifer M. T. A. Meessen, Deborah Novelli, Ursula-Henrike Wienhues-Thelen, Marcello Disertori, Aldo P. Maggioni, Serge Masson, Gianni Tognoni, Maria Grazia Franzosi, Donata Lucci, Roberto Latini |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/15ba99606609469697a5b64268aac08d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The ability of NT-proBNP to detect chronic heart failure and predict all-cause mortality is higher in elderly Chinese coronary artery disease patients with chronic kidney disease
por: Fu S, et al.
Publicado: (2013) -
Relationship between fragmented QRS and NT proBNP in patients with ST elevation myocardial infarction who underwent primary percutaneous coronary intervention
por: Sunil Subhash Bobade
Publicado: (2021) -
The Ratio of NT-proBNP to CysC1.53 Predicts Heart Failure in Patients With Chronic Kidney Disease
por: Sheng Wang, et al.
Publicado: (2021) -
NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
por: Zuoan Qin, et al.
Publicado: (2021) -
Role of NT-pro BNP in predicting mortality in heart failure
por: Kamal Kant Jena, et al.
Publicado: (2021)